UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000038823 |
|---|---|
| Receipt number | R000044267 |
| Scientific Title | Effectiveness Of Atorvastatin On Dyslipidemic Erectile Dysfunction Patients |
| Date of disclosure of the study information | 2019/12/09 |
| Last modified on | 2024/03/13 08:19:25 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Effectiveness Of Atorvastatin On Dyslipidemic Erectile Dysfunction Patients
Acronym
Effectiveness Of Atorvastatin On Dyslipidemic Erectile Dysfunction Patients
Scientific Title
Effectiveness Of Atorvastatin On Dyslipidemic Erectile Dysfunction Patients
Scientific Title:Acronym
Effectiveness Of Atorvastatin On Dyslipidemic Erectile Dysfunction Patients
Region
| Africa |
Condition
Condition
Erectile dysfunction
Classification by specialty
| Urology |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
Evaluation of the efficacy of atorvastatin in patiens with ED due to hyperlipidemia
Basic objectives2
Safety,Efficacy
Basic objectives -Others
Trial characteristics_1
Confirmatory
Trial characteristics_2
Explanatory
Developmental phase
Assessment
Primary outcomes
improvement in international index of erectile function
Key secondary outcomes
lowering of hyperlipidemia
Base
Study type
Interventional
Study design
Basic design
Parallel
Randomization
Non-randomized
Randomization unit
Blinding
Open -no one is blinded
Control
Placebo
Stratification
NO
Dynamic allocation
NO
Institution consideration
Institution is considered as adjustment factor in dynamic allocation.
Blocking
NO
Concealment
Central registration
Intervention
No. of arms
2
Purpose of intervention
Treatment
Type of intervention
| Medicine |
Interventions/Control_1
30 patients will receive atorvastatin
Interventions/Control_2
30 patients will receive placebo
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 30 | years-old | <= |
Age-upper limit
| 50 | years-old | >= |
Gender
Male
Key inclusion criteria
All patients with ED due to hyperlipidemia
Key exclusion criteria
Any patient with systemic illnesses other than hyperlipidemia
Target sample size
60
Research contact person
Name of lead principal investigator
| 1st name | sameh |
| Middle name | fayek |
| Last name | gamalel din |
Organization
Kasr AlAiny faculty of medicine
Division name
Andrology & STDs
Zip code
202
Address
Elmanial Alsaray street
TEL
01227109309
samehfayek@hotmail.com
Public contact
Name of contact person
| 1st name | sameh |
| Middle name | fayek |
| Last name | gamalel din |
Organization
Kasr AlAiny faculty of medicine
Division name
Andrology & STDs
Zip code
202
Address
Elmanial Alsaray street
TEL
01227109309
Homepage URL
http://scholar.cu.edu.eg/sfayek
samehfayek@hotmail.com
Sponsor or person
Institute
Kasr Alainy faculty of medicine
Institute
Department
Personal name
Funding Source
Organization
Kasr Alainy faculty of medicine
Organization
Division
Category of Funding Organization
Self funding
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
AlAzhar university faculty of medicine
Address
Madinet Nasr, Abbassia, Cairo
Tel
+20 2 904 051
samehfayek@hotmail.com
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2019 | Year | 12 | Month | 09 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Terminated
Date of protocol fixation
| 2019 | Year | 07 | Month | 12 | Day |
Date of IRB
| 2019 | Year | 09 | Month | 10 | Day |
Anticipated trial start date
| 2019 | Year | 09 | Month | 18 | Day |
Last follow-up date
| 2020 | Year | 03 | Month | 04 | Day |
Date of closure to data entry
| 2020 | Year | 03 | Month | 04 | Day |
Date trial data considered complete
| 2020 | Year | 03 | Month | 04 | Day |
Date analysis concluded
| 2020 | Year | 03 | Month | 04 | Day |
Other
Other related information
Management information
Registered date
| 2019 | Year | 12 | Month | 08 | Day |
Last modified on
| 2024 | Year | 03 | Month | 13 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000044267
